Δευτέρα 22 Απριλίου 2019

ClinicalTrials : Head and Neck Neoplasms

To Evaluate the Efficacy and Safety of SCB01A in Subjects With r/m Squamous Cell Head and Neck Cancer
Condition:   Head and Neck Neoplasms
Intervention:   Drug: SCB01A
Sponsor:   SynCore Biotechnology Co., Ltd.
Terminated


Study of the Combination of Panitumumab With Paclitaxel as First-line Treatment of Subjects With Head and Neck Cancer
Condition:   Head and Neck Cancer
Intervention:   Drug: Panitumumab + paclitaxel
Sponsors:   Grupo Español de Tratamiento de Tumores de Cabeza y Cuello;   Amgen;   Trial Form Support S.L.
Completed


The Effects on Auditory Function of RADiotherapy and Chemotherapy Treatments for Head and Neck Tumours (EARAD)
Conditions:   Head and Neck Neoplasms;   Hearing Loss
Intervention:   
Sponsor:   University of Manchester
Not yet recruiting


A Phase I/II Clinical Trial of PepCan in Head and Neck Cancer Patients
Condition:   Head and Neck Cancer
Intervention:   Biological: PepCan
Sponsor:   University of Arkansas
Not yet recruiting


NUTRI-HAB - Posttreatment Rehabilitation of Nutrition Impact Symptoms in Head and Neck Cancer Survivors
Condition:   Head and Neck Cancer
Intervention:   Other: NUTRI-HAB
Sponsors:   Odense University Hospital;   REHPA The Danish Knowledge Centre for rehabilitation and Palliative Care;   University of Southern Denmark;   University College Copenhagen;   Odense Patient Data Explorative Network;   Rigshospitalet, Denmark
Enrolling by invitation


Comparison of Endoscopic Visualization and CT Imaging of Head and Neck Cancers With Pathological Validation Study
Condition:   Head and Neck Cancer
Intervention:   
Sponsor:   University Health Network, Toronto
Recruiting


A Trial of Concurrent Radiation Therapy, Cisplatin, and BMX-001 in Locally Advanced Head and Neck Cancer
Condition:   Head and Neck Cancer
Interventions:   Drug: BMX-001;   Radiation: Radiation Therapy;   Drug: Cisplatin
Sponsors:   BioMimetix JV, LLC;   Duke University
Recruiting


Feasibility of Imaging in the Treatment of Patients With Advanced Head and Neck Cancer
Condition:   Head and Neck Cancer
Intervention:   Drug: 99mTc-EC-DG
Sponsor:   University of Chicago
Completed


Sensor-Assisted Prevention of Dehydration in Head and Neck Cancer Patients
Condition:   Head and Neck Cancer
Interventions:   Behavioral: Quality of Life Survey;   Behavioral: Health Management Surveys;   Other: Monitoring Devices;   Behavioral: Symptoms Surveys;   Behavioral: Device Usability Survey
Sponsors:   M.D. Anderson Cancer Center;   National Cancer Institute (NCI)
Active, not recruiting


Response to Intermittent Pneumatic Compression Therapy in Head and Neck Cancer-Related Lymphedema
Conditions:   Head and Neck Neoplasms;   Head and Neck Lymphedema;   Head and Neck Cancer
Interventions:   Device: Head and neck garments for pneumatic compression device;   Drug: NIRFLI with ICG
Sponsor:   Tactile Medical
Completed


Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.